Leaflet MEGACE 160 160mg tablets


Indicated for: cachexia; breast or endometrial cancer

Route of administration: oral

Substance: megestrol (antineoplastic agent)

ATC: L02AB01 (Antineoplastic and immunomodulating agents | Hormones and related agents | Progestogens)

Megestrol is a medication primarily used to treat breast cancer and endometrial cancer. It is also used to stimulate appetite and prevent weight loss in patients with chronic illnesses such as AIDS or advanced cancer.

This drug belongs to the class of progestins and works by altering hormonal balance, inhibiting the growth of hormone-sensitive cancer cells. Additionally, megestrol can help increase body mass by stimulating appetite.

Megestrol is available in tablet or oral suspension form, and the dosage is adjusted based on the condition being treated and the patient's response. Treatment may have side effects such as weight gain, fluid retention, mood changes, or gastrointestinal disturbances.

Patients taking megestrol should be regularly monitored by their doctor, especially if they have a history of thrombosis or other cardiovascular conditions. Pregnant or breastfeeding women should not use this medication.

General data about MEGACE 160 160mg

  • Substance: megestrol
  • Date of last drug list: 01-07-2013
  • Commercial code: W04101002
  • Concentration: 160mg
  • Pharmaceutical form: tablets
  • Quantity: 30
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Pharmaceutical forms available for megestrol

Concentrations available for megestrol

  • 160mg
  • 40mg
  • 40mg/ml